Metastatic Prostate Cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer

BACKGROUND: The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PC) mortality and a 1·6-fold increase in PC incidence with PSA-based screening (at 13 years of follow-up). We evaluated PC incidence by risk category at diagnosis across t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Buzzoni, Carlotta, Auvinen, Anssi, Roobol, Monique J, Carlsson, Sigrid, Moss, Sue M, Puliti, Donella, de Koning, Harry J, Bangma, Chris H, Denis, Louis J, Kwiatkowski, Maciej, Lujan, Marcos, Nelen, Vera, Paez, Alvaro, Randazzo, Marco, Rebillard, Xavier, Tammela T, Teuvo LJ, Villers, Arnauld, Hugosson, Jonas, Schröder, Fritz H, Zappa, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982869/
https://ncbi.nlm.nih.gov/pubmed/25791513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2015.02.042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados